Asset Details
Do you wish to reserve the book?
Inhibition of MEK / ERK signalling pathway promotes erythroid differentiation and reduces HSC s engraftment in ex vivo expanded haematopoietic stem cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inhibition of MEK / ERK signalling pathway promotes erythroid differentiation and reduces HSC s engraftment in ex vivo expanded haematopoietic stem cells
Do you wish to request the book?
Inhibition of MEK / ERK signalling pathway promotes erythroid differentiation and reduces HSC s engraftment in ex vivo expanded haematopoietic stem cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Inhibition of MEK / ERK signalling pathway promotes erythroid differentiation and reduces HSC s engraftment in ex vivo expanded haematopoietic stem cells
2018
Overview
The MEK / ERK pathway is found to be important in regulating different biological processes such as proliferation, differentiation and survival in a wide variety of cells. However, its role in self‐renewal of haematopoietic stem cells is controversial and remains to be clarified. The aim of this study was to understand the role of MEK / ERK pathway in ex vivo expansion of mononuclear cells ( MNC s) and purified CD 34 + cells, both derived from human umbilical cord blood ( hUCB ). Based on our results, culturing the cells in the presence of an inhibitor of MEK / ERK pathway— PD 0325901 ( PD )—significantly reduces the expansion of CD 34 + and CD 34 + CD 38 − cells, while there is no change in the expression of stemness‐related genes ( HOXB 4, BMI 1 ). Moreover, in vivo analysis demonstrates that PD reduces engraftment capacity of ex vivo expanded CD 34 + cells. Notably, when ERK pathway is blocked in UCB ‐ MNC s, spontaneous erythroid differentiation is promoted, found in concomitant with increasing number of burst‐forming unit‐erythroid colony ( BFU ‐E) as well as enhancement of erythroid glycophorin‐A marker. These results are in total conformity with up‐regulation of some erythroid enhancer genes ( TAL 1, GATA 2, LMO 2 ) and down‐regulation of some erythroid repressor genes ( JUN , PU 1 ) as well. Taken together, our results support the idea that MEK / ERK pathway has a critical role in achieving the correct balance between self‐renewal and differentiation of UCB cells. Also, we suggest that inhibition of ERK signalling could likely be a new key for erythroid induction of UCB ‐haematopoietic progenitor cells.
Publisher
John Wiley & Sons, Inc
Subject
We currently cannot retrieve any items related to this title. Kindly check back at a later time.